CUMC-6, a new diploid human cell line derived from a squamous carcinoma of the uterine cervix

Gynecologic Oncology

Volumn 62, Issue 2, 1996, Pages 230-240

  Kim, Jin Woo ^a   Lee, Chun Geun ^b   Cho, Youl Hee ^b   Kim, Jae Hoon ^a   Kim, Sa Jin ^a   Kim, Heung Kee ^a   Park, Tae Chul ^a   Song, Seung Kyu ^a   Namkoong, Sung Eun ^a  

^a The Catholic University of Korea   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRADIOL; HLA DQ ANTIGEN; HLA DR ANTIGEN; PLACENTA PROTEIN; PROGESTERONE; PROTEIN P53; TUMOR MARKER; VIRUS DNA;

ADULT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CELL GROWTH; CELL STRUCTURE; CHROMOSOME 1; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DESMOSOME; DIPLOIDY; FEMALE; GENE AMPLIFICATION; GENE REARRANGEMENT; HLA TYPING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE C MYC; ONCOGENE MYC; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TONOFILAMENT; TRANSMISSION ELECTRON MICROSCOPY; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0030221154     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0221     Document Type: Article

References (46)

1. 1. zur Hausen, H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers, Cancer Res. 49, 4677-4681 (1989).
2. 2. Spence, R. P., Murray, A., Banks, L., Kelland, L. R., and Crawford, L. Analysis of human papillomavirus sequences in cell lines recently derived from cervical cancers, Cancer Res. 48, 324-328 (1988).
3. 3. Bishop, J. M. Molecular themes in oncogenesis, Cell 64, 235-248 (1991).
4. 4. Olah, E., Balogh, E., Kovacs, I., and Kiss, A. Abnormalities of chromosome 1 in relation to human malignant disease, Cancer Genet. Cytogenet. 43, 179-194 (1989).
5. 5. Atkin, N. B., and Baker, M. C. Nonrandom chromosome changes in carcinoma of the cervix uteri. I. Nine near-diploid tumors, Cancer Genet. Cytogenet. 7, 209-222 (1982).
6. 6. HGM 11. Human gene mapping 11: Eleventh International Workshop on Human Gene Mapping, Cytogenet Cell Genet. 58, 1-2200 (1990).
7. 7. Riou, G., Barrois, M., Dutronquay, V., and Orth, G. Presence of papillomavirus DNA sequences, amplification of c-myc and H-ras oncogenes, and enhanced expression of c-myc in carcinomas of the uterine cervix, in Papillomaviruses, molecular and clinical aspects (P. M. Howley and T. R. Broker, Eds.), A. R. Liss, New York, pp. 47-56 (1985).
8. 8. Alitalo, K., and Schwab, M. Oncogene amplification in tumor cells, in Advance in cancer research (G. Klein and S. Weinhouse, Eds.), Academic Press, San Diego, pp. 235-281 (1986).
9. 9. Ocadiz, R., Sauceda, R., Cruz, M., Graef, A. M., and Gariglio, P. High correlation between molecular alteration of the c-myc oncogene and carcinoma of the uterine cervix, Cancer Res. 47, 4173-4177 (1987).
10. 10. Durst, M., Croce, C. M., Gissmann, L., Schwarz, E., and Huebner, K. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas, Proc. Natl. Acad. Sci. USA 84,1070-1074 (1987).
11. 11. Neel, B. G., Jhanwar, S. C., Chaganti, R. S. K., and Hayward, W. S. Two human c-onc genes are located on the long arm of chromosome 8, Proc. Natl. Acad. Sci. USA 79, 7842-7846 (1982).
12. 12. Nau, M. M., Brooks, B. J., Battey, J., Sausville, E., Gazdar, A. F., Kirsch, I. R., McBride, O. W., Bertness, V., Hollis, G. F., and Minna, J. D. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer, Nature 318, 69-73 (1985).
13. 13. Crook, T., Wrede, D., Tidy, J. A., Mason, W. P., Evans, D. J., and Vousden, K. H. Clonal p53 mutation in primary cervical cancer: Association with human-papillomavirus-negative tumours, Lancet 339, 1070-1073 (1992).
14. 14. Fujita, M., Inoue, M., Tanizawa, O., Iwamoto, S., and Enomoto, T. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection, Cancer Res. 52, 5323-5328 (1992).
15. 15. Paquette, R. L., Lee, Y. Y., Wilczynski, S. P., Karmakar, A., Kizaki, M., Miller, C. W., and Koeffler, H. P. Mutations of p53 and human papillomavirus infection in cervical carcinoma, Cancer 72, 1272-1280 (1993).
16. 16. Atkin, N. B., and Baker, M. C. Chromosome 17p loss in carcinoma of the cervix uteri, Cancer Genet. Cytogenet. 37, 229-233 (1989).
17. 17. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, Cell 63, 1129-1136 (1990).
18. 18. Crook, T., Fisher, C., and Vousden, K. H. Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression, J. Virol. 65, 505-510 (1991).
19. 19. Ross, G. T. Clinical relevance of research on the structure of human chorionic gonadotropin, Am. J. Obstet. Gynecol 129, 795-805 (1977).
20. 20. Smith, J. B., and O'Neill, R. T. Alpha-fetoprotein: Occurrence in germinal cell and liver malignancies, Am. J. Med. 51, 767-772 (1971).
21. 21. Hunter, R. E., Longcope, C., and Keough, P. Steroid hormone receptors in carcinoma of the cervix, Cancer 60, 392-396 (1987).
22. 22. Harris, H., and Hopkinson, D. A. Handbook of enzyme electrophoresis in human genetics, Elsevier/North-Holland Biomedical Press, Amsterdam (1976).
23. 23. Trent, J. M., and Salmon, S. E. Karyotypic analysis of human ovarian carcinoma cells cloned in short term agar culture, Cancer Genet. Cytogenet. 3, 279-291 (1981).
24. 24. Pathak, S. Chromosome banding techniques, J. Reprod. Med. 17, 25-28 (1976).
25. 25. Bobrow, M., and Madan, K. The effect of various banding procedures in human chromosomes studied with acridine orange, Cytogenet. Cell. Genet. 12, 145-156 (1973).
26. 26. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular cloning: A laboratory manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989).
27. 27. Saiki, R. K., Bugawan, T. I., Horn, G. T., Mullis, K. B., and Erlich, H. A. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele specific oligonucleotide probes, Nature 324, 163-166 (1986).
28. 28. Marsh, G. E. S., and Bodmer, J. G. HLA class II nucleotide sequences, in Proceedings of the Eleventh International Histocompatibility Workshop and conference (K. Jsuji, M. Aizawa, and T. Sasazuki, Eds.), Oxford Sci., Oxford, Vol. I, pp. 32-62 (1992).
29. 29. Ferre, F., and Garduno, F. Detection of human papillomavirus types 6/11, 16 and 18 using the polymerase chain reaction, Cancer Cells 7, 215-218 (1989).
30. 30. Evander, M., Boden, E., Bjersing, L., Rylander, E., and Wadell, G. Oligonucleotide primers for DNA amplification of the early regions 1, 6, and 7 from human papillomavirus types 6, 11, 16, 18, 31, and 33, Arch. Virol. 116, 221-233 (1991).
31. 31. Southern, E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis, J. Mol. Biol. 98, 504-517 (1975).
32. 32. Schreiber, G., and Dubeau, L. c-myc protooncogene amplification detected by polymerase chain reaction in archival human ovarian carcinoma, Am. J. Pathol 137(3), 653-658 (1990).
33. 33. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms, Proc. Natl. Acad. Sci. USA 86, 2766-2770 (1989).
34. 34. Buchman, V. L., Chumakov, P. M., Ninkina, N. N., Samarina, O. P., and Georgiev, G. P. A variation in the structure of the protein-coding regions of the human p53 gene, Gene 70, 245-252 (1988).
35. 35. Patillo, R. A., Hussa, R. O., Story, M. T., Ruckert, A. C. F., Shalaby, M. R., and Mattingly, R. F. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line, Science 196, 1456-1458 (1977).
36. 36. Nozawa, S., Udagawa, Y., Ohta, H., Kurihawa, S., and Fishman, W. H. Newly established uterine cervical carcinoma cell line (SKG-III) with Regan isoenzyme, human chorionic gonadotrophin β-subunit, and pregnancy specific β1-glycoprotein phenotypes, Cancer Res. 43, 1748-1760 (1983).
37. 37. Wank, R., and Thomssen, C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3, Nature 352, 723-725 (1991).
38. 38. Durst, M., Dzarlieva-Petrusevska, R. T., Boukamp, P., Fusenig, N. E., and Gissmann, L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA, Oncogene 1, 251-256 (1987).
39. 39. Durst, H., Gallahan, D., Gilbert, J., and Rhim, J. S. Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene, Virology 173, 767-771 (1989).
40. 40. Atkin, N. B., Baker, M. C., and Fox, M. F. Chromosome changes in 43 carcinomas of the cervix uteri, Cancer Genet. Cytogenet. 44, 229-241 (1990).
41. 41. Choo, K. B., Chong, K. Y., Chou, H. F., Liew, L. N., and Liou, C. C. Analysis of the structure and expression of the c-myc oncogene in cervical tumor and in cervical tumor-derived cell lines, Biochem. Biophys. Res. Commun. 158, 334-340 (1989).
42. 42. Alitalo, K., Koskinen, P., Makela, T. P., Saksela, K., Sistonen, L., and Winqvist, R. myc oncogenes: activation and amplification, Biochim. Biophys. Acta 907, 1-32 (1987).
43. 43. Weinberg, R. A. Tumor suppressor genes, Science 254, 1138-1146 (1991).
44. 44. Scheffner, M., Munger, K., Byrne, J. C., and Howley, P. M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines, Proc. Natl. Acad. Sci. USA 88, 5523-5527 (1991).
45. 45. Crook, T., Wrede, D., Vousden, K. V. p53 point mutations in HPV negative human cervical carcinoma cell lines, Oncogene 6, 873-875 (1991).
46. 46. Yaginuma, Y., and Westphal, H. Analysis of the p53 gene in human uterine carcinoma cell lines, Cancer Res. 51, 6506-6509 (1991).